NDC 76297-006 Anticoagulant Sodium Citrate

Trisodium Citrate Dihydrate Solution Extracorporeal - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
76297-006
Proprietary Name:
Anticoagulant Sodium Citrate
Non-Proprietary Name: [1]
Trisodium Citrate Dihydrate
Substance Name: [2]
Trisodium Citrate Dihydrate
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route(s): [4]
  • Extracorporeal - Administration outside of the body.
  • Labeler Name: [5]
    Laboratorios Grifols Sa
    Labeler Code:
    76297
    FDA Application Number: [6]
    BA125697
    Marketing Category: [8]
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date: [9]
    10-25-2019
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 76297-006-01

    Package Description: 28 BAG in 1 CARTON / 250 mL in 1 BAG (76297-006-02)

    NDC Code 76297-006-03

    Package Description: 30 BAG in 1 CARTON / 250 mL in 1 BAG (76297-006-02)

    Product Details

    What is NDC 76297-006?

    The NDC code 76297-006 is assigned by the FDA to the product Anticoagulant Sodium Citrate which is a human prescription drug product labeled by Laboratorios Grifols Sa. The generic name of Anticoagulant Sodium Citrate is trisodium citrate dihydrate. The product's dosage form is solution and is administered via extracorporeal form. The product is distributed in 2 packages with assigned NDC codes 76297-006-01 28 bag in 1 carton / 250 ml in 1 bag (76297-006-02), 76297-006-03 30 bag in 1 carton / 250 ml in 1 bag (76297-006-02). This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are Anticoagulant Sodium Citrate Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
    • TRISODIUM CITRATE DIHYDRATE 40 mg/mL - Sodium salts of citric acid that are used as buffers and food preservatives. They are used medically as anticoagulants in stored blood, and for urine alkalization in the prevention of KIDNEY STONES.

    Which are Anticoagulant Sodium Citrate UNII Codes?

    The UNII codes for the active ingredients in this product are:

    • TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K)
    • ANHYDROUS CITRIC ACID (UNII: XF417D3PSL) (Active Moiety)

    Which are Anticoagulant Sodium Citrate Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    Which are the Pharmacologic Classes for Anticoagulant Sodium Citrate?

    A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es) corresponding to the active ingredients of this product.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".